[HTML][HTML] Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

…, C Genecand, A Iten, F Jacquérioz, L Kaiser, P Vetter… - Nature medicine, 2022 - nature.com
Infectious viral load (VL) expelled as droplets and aerosols by infected individuals partly
determines transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …

[HTML][HTML] Novel SARS-CoV-2 variants: the pandemics within the pandemic

E Boehm, I Kronig, RA Neher, I Eckerle, P Vetter… - Clinical Microbiology …, 2021 - Elsevier
Background Many new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been termed variants of concern/interest (VOC/I) because of the greater risk …

[HTML][HTML] Long-term consequences of COVID-19: research needs

D Yelin, E Wirtheim, P Vetter, AC Kalil… - The Lancet Infectious …, 2020 - thelancet.com
Weeks and months after the onset of acute COVID-19, people continue to suffer. Paul Garner,
a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on the …

[HTML][HTML] Clinical management of Ebola virus disease in the United States and Europe

…, RT Davey Jr, AM Liddell, T Wolf, P Vetter… - … England Journal of …, 2016 - Mass Medical Soc
Background Available data on the characteristics of patients with Ebola virus disease (EVD)
and clinical management of EVD in settings outside West Africa, as well as the …

Clinical features of covid-19

P Vetter, DL Vu, AG L'Huillier, M Schibler, L Kaiser… - Bmj, 2020 - bmj.com
In January 2020, coronavirus SARS-CoV-2 was identified as the cause of an outbreak of
severe pneumonia, now known to be a complication of the coronavirus disease 2019 (covid-19)…

[HTML][HTML] Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

M Bekliz, K Adea, P Vetter, CS Eberhardt… - Nature …, 2022 - nature.com
Emerging SARS-CoV-2 variants raise questions about escape from previous immunity. As
the population immunity to SARS-CoV-2 has become more complex due to prior infections …

Ebola virus shedding and transmission: review of current evidence

P Vetter, WA Fischer, M Schibler… - The Journal of …, 2016 - academic.oup.com
Background. The magnitude of the 2013–2016 Ebola virus disease outbreak in West Africa
was unprecedented, with >28 500 reported cases and >11 000 deaths. Understanding the …

Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron

…, A Iten, F Jacquérioz Bausch, L Kaiser, P Vetter… - MedRxiv, 2022 - medrxiv.org
Background Viral load (VL) is one determinant of secondary transmission of SARS-CoV-2.
Emergence of variants of concerns (VOC) Alpha and Delta was ascribed, at least partly, to …

[HTML][HTML] Sequelae of Ebola virus disease: the emergency within the emergency

P Vetter, L Kaiser, M Schibler, I Ciglenecki… - The Lancet Infectious …, 2016 - thelancet.com
As the massive outbreak of Ebola virus disease (EVD) in west Africa wanes, it has become
increasingly clear that thousands of survivors have many sequelae, some of which might be …

Ebola virus disease complications as experienced by survivors in Sierra Leone

A Tiffany, P Vetter, J Mattia, JA Dayer… - Clinical Infectious …, 2016 - academic.oup.com
Background. Thousands of people have survived Ebola virus disease (EVD) during the
ongoing outbreak. However, data about the frequency and risk factors of long-term post-EVD …